Startups doing autonomous scientific experimentation (self-driving labs)
August 26 at 09:20 · $0.093 total
Self-Driving Labs: Sourcing List
1. Emerald Cloud Lab — Remote-controlled, fully automated wet lab accessible via code/software interface. Fits as category pioneer; scaled facility in Austin, used by pharma and academic groups (CMU built a cloud lab on their platform). More mature, but anchors the space.
2. Chemify — Spinout from Lee Cronin's lab (Glasgow) digitizing chemistry into executable code ("chemputers") for autonomous synthesis. Raised ~$43M Series A (2023); strong IP moat in chemical programming language + hardware.
3. Atinary Technologies — Swiss/US startup offering no-code ML platform (SDLabs) for self-driving experimentation and optimization in chemistry/materials. Early-stage, partnerships with materials and chem companies; genuinely lesser-known.
4. Multiply Labs — Robotic cloud manufacturing for cell therapies and pharmaceuticals; automates GMP processes with robotic arms. Series A+ backed by Casdin/Lux; strong traction with cell-therapy CDMOs.
5. Reshape Biotech — Copenhagen-based; robotic platforms that autonomously run and image microbiology experiments end-to-end. Raised $20M Series A (2023, Astanor); sells to major biotech/agbio R&D teams — under-the-radar in the US.
6. Sphinx Bio (verify current status) — If uncertain, substitute: Trilobio — Full-stack modular robotic platform aiming at fully autonomous biology labs where protocols are portable/reproducible. Seed-stage (Y Combinator), founders ex-Opentrons ecosystem; classic early SDL bet.
7. Iris Light Technologies / alternative — Lila Sciences — Flagship Pioneering's "scientific superintelligence" venture pairing AI with autonomous labs across life and chemical sciences. Launched 2025 with ~$200M; big signal event validating the category.
8. Orbital Materials — AI foundation models for materials discovery paired with automated experimental validation loops (advanced materials, carbon capture). Founded by ex-DeepMind; ~$16M A round — early but credible team.
9. Ginkgo Bioworks' spinoff-adjacent alternative — Medra AI — Building AI-guided robotic systems ("robotic scientists") to automate wet-lab experimentation with adaptable general-purpose robotics. Seed-stage, SF-based; lesser-known, strong robotics+bio founding DNA.
10. Uncountable — Software platform for experimental design/Bayesian optimization in materials & chemicals R&D, increasingly integrating with automated lab hardware. Bootstrapped-to-profitable with enterprise chemical customers; SDL "brain" layer without hardware risk.
---
White-Space Gaps
1. The middleware/orchestration layer is unowned. Everyone builds either full-stack hardware (expensive, slow) or optimization software. There's no dominant "ROS for labs" — a hardware-agnostic scheduling/orchestration standard that lets heterogeneous instruments from different vendors run closed-loop experiments. Whoever wins this becomes the OS of every SDL.
2. Self-driving labs for formulation & specialty chemicals, not just discovery. Most capital chases drug discovery and battery materials. Massive, unsexy markets — coatings, adhesives, cosmetics, food science — have combinatorial formulation problems perfectly suited to autonomous experimentation, with faster sales cycles and no FDA risk. Almost no dedicated early-stage players.
Note: I've flagged where I have lower confidence (e.g., #6); recommend confirming current operating status before outreach, as this space has fast churn.
- Arctoris — Operates a robotic, cloud-based drug-discovery laboratory that runs cellular and molecular experiments continuously and captures the resulting data in a structured platform. Why it fits: Founded in 2016 and based in Oxford; it has raised venture funding and is one of the clearest early examples of an end-to-end autonomous drug-discovery lab.
- Strateos — Provides remotely operated robotic laboratories for biology and chemistry, allowing customers to specify workflows that are executed and monitored automatically. Why it fits: A real, venture-backed successor to Transcriptic; its cloud-lab infrastructure is already used for repeatable, highly automated experimentation rather than merely instrument control.
- Emerald Cloud Lab — Offers a large centralized laboratory in which users program experiments across hundreds of instruments and receive standardized data without physically operating the lab. Why it fits: Commercially deployed and backed by substantial institutional capital; it is more mature than a typical seed startup, but is a foundational platform for self-driving laboratory workflows.
- Kebotix — Combines machine learning, materials databases, and automated laboratory execution to discover and optimize new materials. Why it fits: Founded in 2018 and venture-backed; its explicit “closed-loop” materials-discovery model connects prediction, synthesis, testing, and model updating.
- Chemify — Develops AI-guided chemistry software and automated chemical laboratories intended to plan, execute, and iterate synthesis autonomously. Why it fits: UK-based and founded in 2019; it has attracted significant backing and is pursuing a broad “autonomous chemistry” platform rather than a single therapeutic program.
- CuspAI — Uses generative AI and automated experimentation to discover materials with specified properties, including materials relevant to sustainability and industrial applications. Why it fits: A young Cambridge-based company that announced major early funding and partnerships; its model is explicitly oriented toward AI-directed, experimentally validated materials discovery.
- Lila Sciences — Builds “physical intelligence” systems that combine AI scientists, robotics, and laboratory infrastructure to run scientific experiments autonomously. Why it fits: An unusually early and well-capitalized entrant, launched with Flagship Pioneering backing; its stated goal is broad autonomous experimentation across biology, chemistry, and materials science.
- LabGenius — Uses robotic experimentation, machine learning, and evolutionary design loops to engineer therapeutic proteins such as antibodies. Why it fits: Founded in 2012 and backed by major life-science investors; although more advanced than a seed-stage company, its core platform is a genuine closed-loop autonomous experimentation system.
- Culture Biosciences — Provides automated, remotely managed bioreactor experimentation for optimizing microbial and cell-culture processes, with software controlling experiments and analyzing process data. Why it fits: Founded in 2018 and venture-backed; it is particularly relevant to the self-driving-lab thesis in bioprocess development, where experiment execution and feedback can be tightly integrated.
- Atinary Technologies — Provides AI software for experiment design, Bayesian optimization, and laboratory workflow orchestration across chemistry, materials, and process development. Why it fits: A relatively young, venture-backed company founded in 2019; while it is more software-led than the companies operating full robotic labs, it supplies the decision-making layer required to turn automated equipment into a self-driving laboratory.
White-space gaps noticed
- Autonomous scale-up and manufacturing transfer: Most platforms optimize discovery experiments at small scale; there is still limited coverage of the handoff from optimized lab recipes to pilot-scale synthesis, fermentation, formulation, and process control.
- Affordable self-driving labs for ordinary research groups: Many systems require centralized facilities, expensive robotics, or enterprise-scale deployments. A modular, lower-cost platform that could serve university labs and small industrial R&D teams remains relatively underdeveloped.